Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for BRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2025 134.10M
December 31, 2024 251.30M
December 31, 2023 350.10M
December 31, 2022 274.40M
December 31, 2021 282.40M
December 31, 2020 332.20M
December 31, 2019 213.40M
December 31, 2018 239.70M
December 31, 2017 154.40M
December 31, 2016 130.80M
December 31, 2015 229.20M
December 31, 2014 114.30M
December 31, 2013 145.00M
December 31, 2012 133.10M
Date Value
December 31, 2011 87.70M
December 31, 2010 156.10M
December 31, 2009 149.80M
December 31, 2008 106.90M
December 31, 2007 28.21M
December 31, 2006 37.69M
December 31, 2005 49.72M
December 31, 2004 -0.889M
December 31, 2003 -6.085M
December 31, 2002 -11.39M
December 31, 2001 -11.48M
December 31, 2000 -0.202M
December 31, 1999 5.437M
December 31, 1998 -6.535M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Bio-Rad Laboratories, Inc. 532.20M
Illumina, Inc. 1.079B
Revvity, Inc. 580.46M
Thermo Fisher Scientific, Inc. 7.818B
Waters Corp. 629.23M